Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Poulton Stuart sold 189 Karyopharm Therapeutics Inc. shares (Form 4)
Traded Jul 28, 2026 · Filed Jul 30, 2026
On Jul 28, 2026, Poulton Stuart (EVP, Chief Development Officer) sold 189 Karyopharm Therapeutics Inc. shares at US$7.10 for US$1,342, leaving 94,632 shares. Filed Jul 30, 2026 (Form 4).
- Sold
- 189 shares
- Price
- US$7.10
- Value
- US$1,342
- Holding after
- 94,632 shares
- Trading plan
- No
- Role
- EVP, Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Common Stock | Sale | 189 | US$7.10 | 94,632 | Direct |
Source
Related
- Karyopharm Therapeutics Inc.
- Poulton Stuart
- Karyopharm Therapeutics Inc. shareholders
- Form 4 · Poulton Stuart · May 15, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026